BIO-RAD Laboratories director Allison Schwartz exercised Options for 117 shares at $0 per share on 2026-09-01. The post-transaction figures give investors her reported ownership at 1,573 shares before a forfeiture, followed by 1,530 shares, alongside 75 derivative securities.

Key Highlights

  • Allison Schwartz reported ownership of 1,573 shares after the option exercise.
  • A separate forfeiture was priced at $380.96 per share.
  • Schwartz reported 75 derivative securities after the transactions.

BIO-RAD LABORATORIES, INC. (NYSE: BIO) recorded director Allison Schwartz’s exercise of options for 117 shares at $0 per share on 1 September 2026. Her reported ownership after the exercise was 1,573 shares.

Schwartz Reports Share

and Derivative Holdings Schwartz’s activity also included derivative securities, with ownership of 75 after the transactions. A separate forfeiture on 1 September 2026 was priced at $380.96 per share. Her reported share ownership after that transaction was 1,530 shares. The disclosed activity includes the option exercises and the forfeiture.